Literature DB >> 26921425

Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.

Megan K Shaughnessy1, Aleh Bobr2, Michael A Kuskowski3,4, Brian D Johnston5,4, Michael J Sadowsky2, Alexander Khoruts6,2, James R Johnson1,4.   

Abstract

Recurrent Clostridium difficile infection (R-CDI) is common and difficult to treat, potentially necessitating fecal microbiota transplantation (FMT). Although C. difficilespores persist in the hospital environment and cause infection, little is known about their potential presence or importance in the household environment. Households of R-CDI subjects in the peri-FMT period and of geographically matched and age-matched controls were analyzed for the presence ofC. difficile Household environmental surfaces and fecal samples from humans and pets in the household were examined. Households of post-FMT subjects were also examined (environmental surfaces only). Participants were surveyed regarding their personal history and household cleaning habits. Species identity and molecular characteristics of presumptive C. difficile isolates from environmental and fecal samples were determined by using the Pro kit (Remel, USA), Gram staining, PCR, toxinotyping, tcdC gene sequencing, and pulsed-field gel electrophoresis (PFGE). Environmental cultures detected C. difficile on ≥1 surface in 8/8 (100%) peri-FMT households, versus 3/8 (38%) post-FMT households and 3/8 (38%) control households (P= 0.025). The most common C. difficile-positive sites were the vacuum (11/27; 41%), toilet (8/30; 27%), and bathroom sink (5/29; 17%).C. difficile was detected in 3/36 (8%) fecal samples (two R-CDI subjects and one household member). Nine (90%) of 10 households with multiple C. difficile-positive samples had a single genotype present each. In conclusion,C. difficile was found in the household environment of R-CDI patients, but whether it was found as a cause or consequence of R-CDI is unknown. If household contamination leads to R-CDI, effective decontamination may be protective.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26921425      PMCID: PMC4836413          DOI: 10.1128/AEM.03888-15

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  27 in total

1.  Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.

Authors:  S Stubbs; M Rupnik; M Gibert; J Brazier; B Duerden; M Popoff
Journal:  FEMS Microbiol Lett       Date:  2000-05-15       Impact factor: 2.742

2.  Environmental control to reduce transmission of Clostridium difficile.

Authors:  J L Mayfield; T Leet; J Miller; L M Mundy
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

3.  Definition of the single integration site of the pathogenicity locus in Clostridium difficile.

Authors:  V Braun; T Hundsberger; P Leukel; M Sauerborn; C von Eichel-Streiber
Journal:  Gene       Date:  1996-11-28       Impact factor: 3.688

4.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.

Authors:  Lynne V McFarland; Gary W Elmer; Christina M Surawicz
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

6.  Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization.

Authors:  Eijiro Ozaki; Haru Kato; Hiroyuki Kita; Tadahiro Karasawa; Tsuneo Maegawa; Youko Koino; Kazumasa Matsumoto; Toshihiko Takada; Koji Nomoto; Ryuichiro Tanaka; Shinichi Nakamura
Journal:  J Med Microbiol       Date:  2004-02       Impact factor: 2.472

7.  Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics.

Authors:  T V Riley; J E Adams; G L O'Neill; R A Bowman
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

8.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

9.  Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.

Authors:  K H Kim; R Fekety; D H Batts; D Brown; M Cudmore; J Silva; D Waters
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

10.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  13 in total

1.  Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study.

Authors:  Christopher Staley; Matthew J Hamilton; Byron P Vaughn; Carolyn T Graiziger; Krista M Newman; Amanda J Kabage; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

2. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-04       Impact factor: 1.513

Review 3.  Hospital Infection Control: Clostridioides difficile.

Authors:  Nicholas A Turner; Deverick J Anderson
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

4.  Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection.

Authors:  Christopher Staley; Byron P Vaughn; Carolyn T Graiziger; Michael J Sadowsky; Alexander Khoruts
Journal:  J Antimicrob Chemother       Date:  2016-12-20       Impact factor: 5.790

5.  Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.

Authors:  Jay Worley; Mary L Delaney; Christopher K Cummins; Andrea DuBois; Michael Klompas; Lynn Bry
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

Review 6.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

7.  High Prevalence of Clostridium difficile in Home Gardens in Western Australia.

Authors:  Nirajmohan Shivaperumal; Barbara J Chang; Thomas V Riley
Journal:  Appl Environ Microbiol       Date:  2020-12-17       Impact factor: 4.792

Review 8.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

9.  Community Environmental Contamination of Toxigenic Clostridium difficile.

Authors:  M Jahangir Alam; Seth T Walk; Bradley T Endres; Eugenie Basseres; Mohammed Khaleduzzaman; Jonathan Amadio; William L Musick; Jennifer L Christensen; Julie Kuo; Robert L Atmar; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

10.  The zoonotic potential of Clostridium difficile from small companion animals and their owners.

Authors:  Denise Rabold; Werner Espelage; Muna Abu Sin; Tim Eckmanns; Alexander Schneeberg; Heinrich Neubauer; Nadine Möbius; Katja Hille; Lothar H Wieler; Christian Seyboldt; Antina Lübke-Becker
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.